A new CRISPR tool identifies genes behind lymphoma drug resistance, offering new therapeutic targets for fighting cancer progression.







Stanford researchers successfully graft human brain tissue into cortex-depleted mice, unlocking new potential for studying neurodegenerative diseases and brain











A new CRISPR tool identifies genes behind lymphoma drug resistance, offering new therapeutic targets for fighting cancer progression.

Key Takeaways Senior day care provides meaningful social engagement that can support emotional wellness, mental stimulation, and a…

Tumors can hide p53 mutations from T cells, posing challenges for personalized immunotherapy. Researchers find tumors conceal p53…

Experimental gene therapy offers hope for a boy with rare Cockayne syndrome, marking a significant advancement in medical…

Stanford researchers successfully graft human brain tissue into cortex-depleted mice, unlocking new potential for studying neurodegenerative diseases and…

New targeted cancer therapies approved by US authorities broaden precision oncology reach for cancer patients.

AI enhances brain aneurysm detection by 39% but increases false alarms, offering a second set of eyes for…

A low-cost smartphone attachment boosts cataract screening in remote India, enabling community health workers to diagnose and refer…

Targeted mRNA nanoparticles retrain tumor macrophages to boost cancer immunity, offering a promising new immunotherapy strategy.

Chemotherapy causes lasting damage in healthy tissues, leading to DNA damage in children.